AJTCCM VOL. 29 NO. 3 2023 141
PICK OF THE PICS
A 78-year-old woman presented with unilateral pleural thickening
and intraparenchymal pulmonary nodules. e positron emission
tomography (PET) scan showed pleural and peritoneal uptake.
Clinical hypotheses included a pleural tumour inltrating the lung
or vice versa.
Microscopy of the pleural biopsy showed a malignancy with a
predominantly solid architectural pattern and in smaller proportion
papillary, composed of epithelioid cells, with scant cytoplasm and
several mitosis (Fig. 1). Immunohistochemistry showed the following
prole: CK7+; TTF1-; Napsin-; WT1+; Calretinin-; CK5/6-; D2-40-.
TTF1- and Napsin- ruled out a pulmonary origin, however, the
positivity found for WT1 should not be considered separately from
the rest of the immunohistochemistry, leading to a misdiagnosis
of mesothelioma. In fact, the results obtained from the first
immunohistochemical panel applied leads to rule out a mesothelial
nature as well (Calretinin-; CK5/6-; D2-40-).[1] Therefore, the
hypothesis of pleuropulmonary metastasis by a neoplasm with a
CK7+/WT1+ prole was raised, and attention was specically directed
toward a serous histotype.
e immunohistochemical panel was then expanded in that diagnostic
direction and the result was consistent (Fig. 2): PAX8+; CA125+;
p53+; p16+. [2-4]
Radiological/gynaecological investigation showed no uterine or
tubo-ovarian masses. e most likely hypothesis, also considering the
peritoneal wall PET uptake therefore, was a rare primary peritoneal
serous carcinoma.
1. Husain AN, Colby TV, Ordóñez NG, et al. Guidelines for Pathologic Diagnosis
of Malignant Mesothelioma 2017: Update of the Consensus Statement From the
International Mesothelioma Interest Group. Arch Pathol Lab Med 2018;142(1):89-
108. https://doi.org/10.5858/arpa.2017-0124-RA.
2. Anwar A, Kasi A. Peritoneal Cancer. 2022 Feb 24. In: StatPearls. Treasure Island (FL):
StatPearls Publishing; 2022 Jan.
3. Laury AR, Hornick JL, Perets R, et al. PAX8 reliably distinguishes ovarian serous
tumors from malignant mesothelioma. Am J Surg Pathol 2010;34(5):627-35. https://
doi.org/10.1097/PAS.0b013e3181da7687.
4. Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial
antibodies in distinguishing diuse peritoneal mesothelioma in females from serous
papillary carcinoma of the ovary and peritoneum. Histopathology 2002;40(3):237-
244. https://doi.org/10.1046/j.1365-2559.2002.01352.x.
A WT1-positive pleural neoplasm. Is it always a mesothelioma?
Diagnostic pitfall of WT1 immunohistochemistry in pleural
neoplasm
G Gaggero,1 D Taietti,2 M Concardi,3 M Mora1
1 IRCCS Ospedale Policlinico San Martino, UO Anatomia patologica ospedaliera, Genova, Italy
2 Pathology Unit, ASST del Garda, Desenzano del Garda, Brescia, Italy
3 Università di Genova, Scuola di Scienze Mediche e Farmaceutiche, Department of Integrated Surgical and Diagnostic Sciences (DISC), Division of Anatomic
Pathology, Genoa, Italy
Fig. 1 (A). Photomicrograph (histologic staining with haematoxylin-
eosin after formalin fixation and paraffin embedding of the tissue;
magnication: 10x), showing an epithelioid neoplasm (in the middle)
inltrating the pleura (on the right) and with areas of necrosis (on the
left); (B) photomicrograph (histologic staining with haematoxylin-
eosin after formalin fixation and paraffin embedding of the tissue;
magnication: 40x), showing a neoplasm with an architectural pattern
that is partly solid and partly papillary, and cytologically poorly
dierentiated and with numerous mitoses (arrows).
Fig. 2. Photomicrograph, showing the main immunohistochemical
markers useful for the diagnosis of serous carcinoma: (A) intense and
diuse cytoplasmic positivity for CK7; (B) intense and diuse nuclear
positivity for WT1; (C) intense and diuse nuclear positivity for PAX8;
(D) membrane positivity for CA125.